Facing the nuclear threat: thyroid blocking revisited.

Area of Science:

• Nuclear medicine
• Pharmacology
• Radiological protection

Background:

• Radioactive iodine exposure necessitates thyroid prophylaxis to prevent high radiation doses.
• Understanding individual protective effects of pharmacological interventions is crucial.

Purpose of the Study:

• To investigate parameters influencing the individual protective effect of pharmacological interventions for radioactive iodine exposure.
• To compare the efficacy of different dosages and timings of potassium iodide (KI) and sodium perchlorate (SP).

Main Methods:

• Evaluated the biokinetics of radioactive iodine ((123)I) in 27 healthy volunteers.
• Administered single doses of KI or SP at various times relative to exposure.
• Compared seven regimens involving 100 mg KI, 100 mg SP, or 1 g SP.

Main Results:

• Mean thyroid dose reductions ranged from 88.7% at 24 hours before exposure to 2.8% at 24 hours after exposure with KI.
• 1 g SP was as effective as 100 mg KI; 100 mg SP showed residual uptake.
• Individual dose reduction correlated inversely with the effective half-life of iodine in the blood, with faster kinetics observed in younger participants.

Conclusions:

• Current thyroid blocking guidelines are adequate for older individuals but not for younger ones due to faster iodine kinetics.
• Sodium perchlorate (SP) can serve as an alternative for thyroid blocking in individuals with iodine hypersensitivity.